Inflammation in Urological Malignancies: The Silent Killer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
03 Jan 2023
Historique:
received: 17 10 2022
revised: 02 12 2022
accepted: 28 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

Several studies have investigated the role of inflammation in promoting tumorigenesis and cancer progression. Neoplastic as well as surrounding stromal and inflammatory cells engage in well-orchestrated reciprocal interactions to establish an inflammatory tumor microenvironment. The tumor-associated inflammatory tissue is highly plastic, capable of continuously modifying its phenotypic and functional characteristics. Accumulating evidence suggests that chronic inflammation plays a critical role in the development of urological cancers. Here, we review the origins of inflammation in urothelial, prostatic, renal, testicular, and penile cancers, focusing on the mechanisms that drive tumor initiation, growth, progression, and metastasis. We also discuss how tumor-associated inflammatory tissue may be a diagnostic marker of clinically significant tumor progression risk and the target for future anti-cancer therapies.

Identifiants

pubmed: 36614308
pii: ijms24010866
doi: 10.3390/ijms24010866
pmc: PMC9821648
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Tumour Biol. 2015 Apr;36(4):2509-16
pubmed: 25557886
Mol Cancer Ther. 2010 May;9(5):1371-7
pubmed: 20423998
Neoplasia. 2007 Jul;9(7):556-62
pubmed: 17710158
J Infect Dis. 2011 Jul 15;204(2):217-23
pubmed: 21673031
Target Oncol. 2016 Oct;11(5):569-577
pubmed: 27402433
Virchows Arch. 2015 Dec;467(6):623-633
pubmed: 26263854
BMC Cancer. 2013 Jul 01;13:322
pubmed: 23815949
Mol Ther. 2010 Nov;18(11):1947-59
pubmed: 20683443
Diagn Pathol. 2012 Nov 05;7:152
pubmed: 23126361
Cancer Prev Res (Phila). 2015 Apr;8(4):312-7
pubmed: 25644151
Int Urol Nephrol. 2015 Jan;47(1):39-46
pubmed: 25248630
Oncol Rep. 2014 Jul;32(1):235-42
pubmed: 24859482
Clin Genitourin Cancer. 2019 Feb;17(1):e80-e91
pubmed: 30318447
Cancer. 2008 Sep 15;113(6):1387-95
pubmed: 18671239
Mol Oncol. 2018 Aug;12(8):1308-1323
pubmed: 29808619
Nat Med. 2012 Aug;18(8):1254-61
pubmed: 22842478
Clin Cancer Res. 2018 Dec 15;24(24):6125-6135
pubmed: 30049748
Front Immunol. 2018 Jun 11;9:1253
pubmed: 29942303
Cancer Res. 2006 May 15;66(10):5130-42
pubmed: 16707436
Virchows Arch. 2022 Jun;480(6):1159-1169
pubmed: 35024940
Clin Cancer Res. 2005 Apr 1;11(7):2459-65
pubmed: 15814620
Cancer Immunol Immunother. 2016 Feb;65(2):151-60
pubmed: 26728480
Cancer. 2002 Dec 1;95(11):2293-301
pubmed: 12436434
Br J Cancer. 2011 Jun 28;105(1):93-103
pubmed: 21629244
Andrology. 2013 May;1(3):517-29
pubmed: 23495012
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Toxicol Appl Pharmacol. 2013 Oct 1;272(1):30-6
pubmed: 23727622
J Cell Mol Med. 2011 Feb;15(2):187-95
pubmed: 21155973
Arch Phys Med Rehabil. 2002 Mar;83(3):346-51
pubmed: 11887115
Tumour Biol. 2014 Jun;35(6):5401-7
pubmed: 24519067
Int J Mol Sci. 2019 Aug 06;20(15):
pubmed: 31390729
Int J Urol. 2010 Sep;17(9):801-9
pubmed: 20727050
Precis Clin Med. 2018 Jun;1(1):49-56
pubmed: 35694127
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3967-72
pubmed: 17360461
Urol Oncol. 2011 Nov-Dec;29(6):809-14
pubmed: 19945304
Genes Chromosomes Cancer. 2008 Jul;47(7):547-57
pubmed: 18381640
Carcinogenesis. 2009 Mar;30(3):377-86
pubmed: 19136477
Sci Rep. 2017 Feb 20;7:42893
pubmed: 28216616
Urol Oncol. 2013 Feb;31(2):241-6
pubmed: 21292512
Cancer Res. 2017 Mar 1;77(5):1075-1082
pubmed: 27872087
Am J Surg Pathol. 2013 Aug;37(8):1223-8
pubmed: 23681080
Prostate Cancer Prostatic Dis. 2007;10(1):15-29
pubmed: 17199136
World J Urol. 2016 Mar;34(3):425-30
pubmed: 26108732
Oncol Lett. 2017 Aug;14(2):1855-1865
pubmed: 28789421
Cancer Sci. 2011 Jul;102(7):1424-31
pubmed: 21453387
Eur Urol. 2014 Dec;66(6):1078-91
pubmed: 25151017
Transl Androl Urol. 2017 Oct;6(5):791-802
pubmed: 29184775
Am J Pathol. 2004 Jan;164(1):305-13
pubmed: 14695343
J Cell Biol. 2006 Nov 20;175(4):547-54
pubmed: 17101696
Cancer Commun (Lond). 2020 Mar;40(2-3):69-80
pubmed: 32237072
Free Radic Biol Med. 2012 May 1;52(9):2013-37
pubmed: 22391222
Cancer Sci. 2008 May;99(5):905-13
pubmed: 18294286
Biomed J. 2012 Nov-Dec;35(6):437-49
pubmed: 23442356
J Immunother Cancer. 2014 Sep 16;2:31
pubmed: 26196012
J Clin Oncol. 2005 Dec 10;23(35):8959-67
pubmed: 16219934
PLoS One. 2012;7(6):e38972
pubmed: 22701738
Cancer. 2007 Jun 1;109(11):2257-67
pubmed: 17440983
J Pathol. 2009 Jan;217(1):94-102
pubmed: 18839394
Oncol Lett. 2020 Nov;20(5):272
pubmed: 33014151
Cancer Discov. 2016 Mar;6(3):270-85
pubmed: 26715645
BMC Urol. 2012 Jun 13;12:18
pubmed: 22695075
Cancer Prev Res (Phila). 2011 Oct;4(10):1580-9
pubmed: 21881030
J Urol. 2002 Oct;168(4 Pt 1):1568-73
pubmed: 12352459
Virulence. 2010 Mar-Apr;1(2):84-7
pubmed: 21178421
Infect Agent Cancer. 2022 May 30;17(1):23
pubmed: 35637508
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Croat Med J. 2012 Dec;53(6):598-604
pubmed: 23275325
Immunity. 2006 Sep;25(3):361-72
pubmed: 16979568
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2280-7
pubmed: 21953116
Br J Cancer. 2009 Mar 10;100(5):834-9
pubmed: 19174821
PLoS One. 2012;7(1):e30712
pubmed: 22303451
Front Oncol. 2018 Sep 11;8:370
pubmed: 30254983
Int J Androl. 2007 Aug;30(4):377-84; discussion 384
pubmed: 17705810
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
Int J Mol Sci. 2020 Apr 09;21(7):
pubmed: 32283655
Br J Cancer. 2015 Feb 3;112(3):594-600
pubmed: 25429525
Oncogene. 2005 Feb 3;24(6):1043-52
pubmed: 15592504
Int J Exp Pathol. 2000 Jun;81(3):211-7
pubmed: 10971742
Endocr Metab Immune Disord Drug Targets. 2021;21(2):253-267
pubmed: 32682386
Blood. 2003 Feb 15;101(4):1535-42
pubmed: 12393476
Urology. 1999 Feb;53(2):292-7
pubmed: 9933042
Adv Exp Med Biol. 2014;816:197-234
pubmed: 24818725
J Biochem Mol Biol. 2003 Jan 31;36(1):128-37
pubmed: 12542983
Clin Cancer Res. 2007 Mar 1;13(5):1472-9
pubmed: 17332291
Nat Immunol. 2011 Jul 19;12(8):695-708
pubmed: 21772278
J Pathol. 2002 Mar;196(3):254-65
pubmed: 11857487
Nat Rev Immunol. 2004 Dec;4(12):941-52
pubmed: 15573129
Int J Urol. 2000 Jul;7(7):263-9
pubmed: 10910229
Clin Cancer Res. 2007 Apr 1;13(7):2075-81
pubmed: 17404089
Front Endocrinol (Lausanne). 2019 Jun 12;10:355
pubmed: 31263452
PLoS One. 2018 Sep 27;13(9):e0204745
pubmed: 30261082
Mol Immunol. 2011 Jul;48(12-13):1556-67
pubmed: 21601924
Nature. 2003 Sep 18;425(6955):307-11
pubmed: 13679920
Anticancer Res. 2014 Jul;34(7):3537-42
pubmed: 24982366
Am J Cancer Res. 2014 Nov 19;4(6):952-62
pubmed: 25520883
Am J Pathol. 2010 Aug;177(2):943-54
pubmed: 20566746
Mol Cancer. 2016 Nov 3;15(1):68
pubmed: 27809841
Cardiovasc Res. 2001 Feb 16;49(3):568-81
pubmed: 11166270
Oncol Rep. 2012 Dec;28(6):2043-8
pubmed: 22972438
Histol Histopathol. 2016 Feb;31(2):149-57
pubmed: 26521657
Cancer Res. 2011 Oct 15;71(20):6400-9
pubmed: 21900394
J Clin Oncol. 2005 Aug 20;23(24):5746-56
pubmed: 16110031
Int J Clin Exp Med. 2014 Oct 15;7(10):3181-92
pubmed: 25419348
Eur J Cancer. 2002 Oct;38(15):2014-9
pubmed: 12376206
Clin Cancer Res. 2011 Nov 15;17(22):6992-7002
pubmed: 21948231
PLoS One. 2013 May 17;8(5):e62823
pubmed: 23690956
Clin Genitourin Cancer. 2020 Jun;18(3):171-178.e2
pubmed: 32057715
Semin Radiat Oncol. 2017 Jan;27(1):3-10
pubmed: 27986209
Cancer Treat Rev. 2017 Jul;58:41-50
pubmed: 28641100
Cancer Metastasis Rev. 2010 Dec;29(4):709-22
pubmed: 20839032
Clin Cancer Res. 2002 Apr;8(4):945-54
pubmed: 11948098
Biomed Res Int. 2013;2013:791212
pubmed: 23762858
Nat Rev Microbiol. 2005 Apr;3(4):343-9
pubmed: 15806096
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Oncotarget. 2015 Sep 22;6(28):24990-5002
pubmed: 26317902
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Clin Cancer Res. 2001 Oct;7(10):3113-9
pubmed: 11595703
Int J Mol Sci. 2017 Sep 20;18(9):
pubmed: 28930154
Cytokine Growth Factor Rev. 2016 Oct;31:61-71
pubmed: 27578214
Mol Cancer. 2011 Apr 11;10:36
pubmed: 21481239
Scand J Urol Nephrol Suppl. 2008 Sep;(218):79-84
pubmed: 18815920
PLoS Pathog. 2010 Aug 12;6(8):e1001042
pubmed: 20811584
Am J Clin Exp Urol. 2016 Jan 28;4(1):12-6
pubmed: 27069958
J Intern Med. 2000 Sep;248(3):171-83
pubmed: 10971784
Clin Exp Immunol. 2010 Sep;161(3):480-9
pubmed: 20646003
BJU Int. 2013 Nov;112 Suppl 2:27-31
pubmed: 24127673
J Leukoc Biol. 2012 Jan;91(1):167-81
pubmed: 21954284
Curr Opin Immunol. 2010 Apr;22(2):238-44
pubmed: 20171075
J Clin Med. 2020 Aug 18;9(8):
pubmed: 32824865
PLoS One. 2009 Aug 19;4(8):e6695
pubmed: 19690611
Expert Opin Emerg Drugs. 2012 Jun;17(2):135-45
pubmed: 22533737
Int Immunopharmacol. 2011 Jul;11(7):848-55
pubmed: 21315786
Cancer Res. 2007 Oct 1;67(19):9417-24
pubmed: 17909051
Front Immunol. 2017 Dec 14;8:1732
pubmed: 29312291
EClinicalMedicine. 2021 Sep 16;41:101134
pubmed: 34585125
Cells. 2021 Dec 22;11(1):
pubmed: 35011582
Am J Clin Exp Urol. 2014 Oct 02;2(3):231-8
pubmed: 25374925
J Clin Pathol. 2005 Feb;58(2):207-10
pubmed: 15677544
Int Immunopharmacol. 2008 Dec 20;8(13-14):1821-6
pubmed: 18801463
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Cancer. 2009 May 15;115(10 Suppl):2262-72
pubmed: 19402056
Immunobiology. 2009;214(9-10):761-77
pubmed: 19616341
J Hematol Oncol. 2019 Jul 12;12(1):76
pubmed: 31300030
Trends Pharmacol Sci. 2004 Apr;25(4):201-9
pubmed: 15063084
Br J Cancer. 2000 Sep;83(5):637-41
pubmed: 10944605
Clin Cancer Res. 2014 Jun 15;20(12):3198-3210
pubmed: 24740322
Endocr Relat Cancer. 2019 Jan 1;26(1):131-140
pubmed: 30400004
Nat Genet. 2009 Jul;41(7):811-5
pubmed: 19483682
PLoS One. 2013 Apr 30;8(4):e61901
pubmed: 23637926
Eur J Clin Invest. 2008 Oct;38 Suppl 2:21-8
pubmed: 18826478
Clin Cancer Res. 2014 Apr 1;20(7):1925-34
pubmed: 24536060
Biosci Rep. 2021 Jan 29;41(1):
pubmed: 33458757
Oncoimmunology. 2019 Oct 11;8(12):e1672494
pubmed: 31741775
Anticancer Drugs. 2002 Feb;13(2):127-37
pubmed: 11901304
Cancer Sci. 2017 Dec;108(12):2326-2332
pubmed: 28898532
J Clin Oncol. 2002 Nov 1;20(21):4368-80
pubmed: 12409337
Cancers (Basel). 2021 Dec 01;13(23):
pubmed: 34885171
Cancer Immun. 2007 Jun 26;7:10
pubmed: 17591743
Cancer. 2006 Sep 15;107(6):1273-9
pubmed: 16909426
Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(2):25-9
pubmed: 26086164
Oncogene. 2019 Jan;38(3):332-344
pubmed: 30111818
Front Pharmacol. 2013 Mar 14;4:28
pubmed: 23504227
Prostate. 2013 Jun;73(8):789-800
pubmed: 23620238
Prostate. 2011 Sep 15;71(13):1455-65
pubmed: 21321981
Mol Cell Biochem. 2020 Nov;474(1-2):199-208
pubmed: 32737771
Cancer Invest. 2014 Aug;32(7):311-20
pubmed: 24827594
BJU Int. 2011 Nov;108(10):1672-8
pubmed: 21244603
Am J Epidemiol. 1984 Apr;119(4):510-5
pubmed: 6711540
Eur J Cancer. 2009 Jun;45(9):1664-72
pubmed: 19318244
Prostate Int. 2020 Jun;8(2):62-69
pubmed: 32647642
Urol Oncol. 2014 Jan;32(1):51.e1-7
pubmed: 24239459
Cancer Lett. 2011 Jun 28;305(2):239-49
pubmed: 20667649
Spinal Cord. 2010 Mar;48(3):257-61
pubmed: 19752870
Eur Urol. 2009 Oct;56(4):678-88
pubmed: 18513850
Mol Cancer Res. 2012 Aug;10(8):1109-19
pubmed: 22707636
Pathobiology. 2008;75(6):335-45
pubmed: 19096229
Nature. 2001 Mar 1;410(6824):50-6
pubmed: 11242036
J Urol. 2007 Mar;177(3):1163-8
pubmed: 17296438
Hum Pathol. 2013 Aug;44(8):1630-7
pubmed: 23574787
Clin Cancer Res. 2015 Aug 15;21(16):3771-82
pubmed: 25967142
Oncogene. 2015 Apr 23;34(17):2239-50
pubmed: 24931163
Cell Cycle. 2011 Jul 15;10(14):2305-16
pubmed: 21670596
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7319-24
pubmed: 11404481
J Cell Physiol. 2011 May;226(5):1292-307
pubmed: 20945395
Cancer Res. 2009 Jun 1;69(11):4878-84
pubmed: 19487298
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
J Exp Clin Cancer Res. 2021 Dec 1;40(1):378
pubmed: 34852826
Sci Rep. 2021 May 25;11(1):10833
pubmed: 34035396
Virchows Arch. 2015 Mar;466(3):323-31
pubmed: 25544615
J Cancer Res Clin Oncol. 2012 May;138(5):739-43
pubmed: 22258852
Cell Mol Immunol. 2021 Apr;18(4):842-859
pubmed: 33139907
Semin Cancer Biol. 2012 Aug;22(4):289-97
pubmed: 22349514
Am J Pathol. 2019 Nov;189(11):2119-2137
pubmed: 31421072
Arch Biochem Biophys. 2003 Sep 1;417(1):3-11
pubmed: 12921773
Nat Med. 2003 Oct;9(10):1269-74
pubmed: 14502282
Lancet. 2003 Mar 15;361(9361):955-64
pubmed: 12648986
Clin Exp Metastasis. 2015 Feb;32(2):111-24
pubmed: 25617965
Int J Urol. 2013 Oct;20(10):971-8
pubmed: 23421558

Auteurs

Martina Catalano (M)

School of Human Health Sciences, University of Florence, 50134 Florence, Italy.

Giandomenico Roviello (G)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, 50139 Florence, Italy.

Raffaella Santi (R)

Section of Pathological Anatomy, Department of Health Sciences, University of Florence, 50139 Florence, Italy.

Donata Villari (D)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Pietro Spatafora (P)

Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Teaching Hospital, 50134 Florence, Italy.

Ilaria Camilla Galli (IC)

Histopathology and Molecular Diagnostics, Careggi Teaching Hospital, 50139 Florence, Italy.

Francesco Sessa (F)

Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Teaching Hospital, 50134 Florence, Italy.

Francesco Lupo Conte (FL)

School of Human Health Sciences, University of Florence, 50134 Florence, Italy.

Enrico Mini (E)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, 50139 Florence, Italy.

Tommaso Cai (T)

Department of Urology, Santa Chiara Regional Hospital, 38122 Trento, Italy.

Gabriella Nesi (G)

Section of Pathological Anatomy, Department of Health Sciences, University of Florence, 50139 Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH